In This Section

Government Relations

ACNM Government Relations Areas of Focus

  • Representation of nuclear physician's interests before Congress and federal regulatory bodies
  • Monthly government affairs reports
  • Electronic issue alerts
  • FDA activities with respect to review and approval of radiopharmaceuticals
  • NRC quality assurance activities
  • Efforts to influence federal funding for nuclear medicine research
  • Educational and training requirements for NRC licensure
  • Nuclear medicine political action committee

Breaking News

ACNM relays concern about Executive Order 13769, suspending the entry of alien nationals from seven countries, to the US President.  Read ACNM's letter to the president.

ACNM responds to the US Nuclear Regulatory Commission Draft Program-Specific Guidance About Medical Use Licenses (NRC-2016-0122), questioning the utility of the proposed revision.  Read ACNM's response.

Latest News

  • December 11, 2017Nuclear Medicine Community Calls for Funding of Domestic Mo-99 Production
    SNMMI and other societies and organizations in the nuclear medicine community have sent joint letters to the U.S. Senate and House chairs and ranking members of the respective Subcommittees on Energy and Water Development of the Committees on Appropriations, voicing support for $67.4 million to secure a sufficient domestic supply of the medical isotope molybdenum-99 (Mo-99).
  • November 14, 2017SNMMI Submits Comments to NRC on Naturally Occurring and Accelerator-Produced Radioactive Materials
    SNMMI has submitted comments to the NRC on its open petition for rulemaking, asking that its regulations be revised to include radionuclides and their corresponding activities to the list of "Quantities of Licensed Material Requiring Labeling."
  • November 13, 2017SNMMI Commends FDA for Release of Microdose Guidance
    SNMMI recently submitted comments to FDA on its draft guidance for microdose radiopharmaceutical diagnostic drugs.
  • November 3, 2017CMS Issues Final Rules for 2018
    Final rules on Medicare for 2018 include the Physician Fee Schedule (PFS), Hospital Outpatient Prospective Payment System (OPPS) and Quality Payment Program (QPP). This is a preliminary summary of how the rules affect nuclear medicine and molecular imaging. There are some tweaks, but no major surprises or changes. For example, the mandate that referring physician consult Appropriate Use Criteria (AUCs) is pushed back from 2018 to 2020.
  • November 1, 2017Cardiac PET Coverage to be Expanded in Florida
    Medicare's contractor in Florida has announced it will expand its coverage for cardiac PET in Florida. The change was requested by SNMMI, ASNC and ACC.
  • View All Government Relations News »